Moderna Inc said on Monday it has applied for U.S. emergency authorization for its COVID-19 vaccine after full results from a late-stage study showed it was 94.1% effective with no serious safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback